Daxor Fair Value
DX
The fair market value of DX5.F stock is 0.45 EUR. Relative to the market price of 8.1 EUR Daxor is overvalued by 94.8%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Daxor Valuation
Current DX5.F share ticker price is 8.1 EUR.
The fair value level of 0.45 EUR can be considered as an effective entry point for long-term investors to start investing in DX5.F stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 94% higher its fair value
Current price is 96% higher its minimum value
Current price is 27% higher its maximum value
Market price:
DX5.F stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Daxor Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
157.27
2
Median P/E over 5 years
11.88
3
Minimum P/E over 5 years
8.37
4
Earning per share (last 12 months)
0.04 USD
Maximum value
1
x
4
=
5.94 EUR
Fair value
2
x
4
=
0.45 EUR
Minimum value
3
x
4
=
0.32 EUR
Daxor Corp price metrics
-0.6
Annual return (geometric mean)
63.1
Risk (standard deviation) of returns
β
0.0
Beta (volatility compared to market)